Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report

Cancer Biology & Medicine

Thomas J O'Neill¹  Alireza Torabi¹  Sumit Gaur² 

[1] ;Divisions of 1 Hematology-Oncology, 2 Pathology, and 3 Radiology, Texas Tech University Health Science Center, TX 79905, USA;

关键词: hemangioendothelioma;    angiogenesis inhibitors;    nab-paclitaxel;    bevacizumab;   

DOI  :  10.3969/j.issn.2095-3941.2012.02.010

来源: DOAJ

【 摘 要 】

This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed.

【 授权许可】

Unknown